ker-050
keros therapeutics
['ker-050', 'keros', '$kros']
keros therapeutics presents clinical trial and preclinical study results from its ker-050 program and preclinical data from its alk2 inhibitor program at the 28th annual congress of the european hematology association - health stocks hub $kros 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2